Regulatory agilities impacting review timelines for Pfizer/BioNTech’s BNT162b2 mRNA COVID-19 vaccine: a retrospective study

The appropriate use of regulatory agilities has the potential to accelerate regulatory review, utilize resources more efficiently and deliver medicines and vaccines more rapidly, all without compromising quality, safety and efficacy. This was clearly demonstrated during the COVID-19 pandemic where r...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Prisha, Macdonald, Judith C., Boobalan, Jayanthi, Marsden, Matthew, Rizzi, Ruben, Zenon, Marianne, Ren, Jinma, Chu, Haitao, Cappelleri, Joseph C., Roychoudhury, Satrajit, O’Brien, Julie, Izaki-Lee, Konoha, Boyce, Donna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664654/
https://www.ncbi.nlm.nih.gov/pubmed/38020129
http://dx.doi.org/10.3389/fmed.2023.1275817

Ejemplares similares

Ejemplares similares